miR-34C Disrupts the Stemness of Purified CD133+ Prostatic Cancer Stem Cells

被引:8
|
作者
Chen, Yuan
Rao, Qun
Zhang, Huiping
Xu, Hua
Zhang, Cuntai
Zhuang, Qianyuan
Ye, Zhangqun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430030, Peoples R China
关键词
ANDROGEN RECEPTOR; THERAPY; IDENTIFICATION; EXPRESSION; RESISTANCE; MICRORNA; PROMOTES;
D O I
10.1016/j.urology.2016.07.021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To find the potential micro-RNA (miRNA) that could determine the fate of prostate cancer stem cells. MATERIALS AND METHODS We compared miRNA expression between our purified CD133(+) prostatic cancer stem cells (PCSCs) and CD133-cells. Sphere formation assay and matrigel-based cell invasion assay were applied to determine the stemness of CD133(+) PCSCs after our manipulation of miRNA using miRNA mimic or miRNA inhibitor. RESULTS In this study, we identified that miR-34C was under-expressed in the purified CD133(+) PCSCs and enforced introduction of miR-34C attenuated the stemness of CD133(+) PCSCs. Clinically, we also observed a negative correlation between miR-34C and CD133. CONCLUSION Our data strongly suggest that miR-34C may play essential role in conferring castration resistance by equilibrating PSCS population. (C) 2016 Elsevier Inc.
引用
收藏
页码:177.e1 / 177.e9
页数:9
相关论文
共 50 条
  • [41] CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
    Piao, Lian Shu
    Hur, Wonhee
    Kim, Taek-Kyun
    Hong, Sung Woo
    Kim, Sung Woo
    Choi, Jung Eun
    Sung, Pil Soo
    Song, Myeong Joon
    Lee, Byeong-Chel
    Hwang, Daehee
    Yoon, Seung Kew
    CANCER LETTERS, 2012, 315 (02) : 129 - 137
  • [42] CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
    Liu, Kai
    Hao, Meijun
    Ouyang, Yabo
    Zheng, Jiasheng
    Chen, Dexi
    SCIENTIFIC REPORTS, 2017, 7
  • [43] Clinical Labeling and Imaging of Transplanted CD133+/CD34+ Stem Cells in Patients with Ischemic Heart Disease
    Ghodsizad, Ali
    Bordel, Viktor
    Bruckner, Brian
    Loebe, Mathias
    Fuerst, Gunter
    Mirsaidi, I.
    Sucker, M.
    Ruhparwar, Arjang
    Karck, Matthias
    Klein, Hans Michael
    HEART SURGERY FORUM, 2012, 15 (02): : 116 - 118
  • [44] Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT
    Huang, Haili
    Hu, Min
    Li, Peng
    Lu, Caijie
    Li, Mingyi
    TUMOR BIOLOGY, 2015, 36 (02) : 921 - 928
  • [45] Role of CD133+ cells in tongue squamous carcinomas: Characteristics of 'stemness' in vivo and in vitro
    Wang, Kai
    Zhou, Xiao-Kang
    Wu, Min
    Kang, Fei-Wu
    Wang, Zuo-Lin
    Zhu, Yan
    ONCOLOGY LETTERS, 2016, 12 (02) : 863 - 870
  • [46] miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells
    Tsukasa, Koichiro
    Ding, Qiang
    Miyazaki, Yumi
    Matsubara, Shyuichiro
    Natsugoe, Shoji
    Takao, Sonshin
    HUMAN CELL, 2016, 29 (03) : 130 - 137
  • [47] miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells
    Koichiro Tsukasa
    Qiang Ding
    Yumi Miyazaki
    Shyuichiro Matsubara
    Shoji Natsugoe
    Sonshin Takao
    Human Cell, 2016, 29 : 130 - 137
  • [48] CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
    Sook-Kyoung Heo
    Eui-Kyu Noh
    Lan Jeong Ju
    Jun Young Sung
    Yoo Kyung Jeong
    Jaekyung Cheon
    Su Jin Koh
    Young Joo Min
    Yunsuk Choi
    Jae-Cheol Jo
    BMC Cancer, 20
  • [49] Inhibition of cervical carcinoma cells proliferation by miR-34c
    Lopez, Jesus A.
    Sales, Luis M. Alvarez
    CANCER RESEARCH, 2010, 70
  • [50] Positive enrichment of CD133+ (AC133+) cells with the CliniMACS device: comparison to CD34
    Schumm, M
    Lang, P
    Kuci, S
    Greil, J
    Niethammer, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S211 - S211